STOCK TITAN
  1. Home
  2. News
  3. CE

Celanese Corp - CE STOCK NEWS

Welcome to our dedicated news page for Celanese (Ticker: CE), a resource for investors and traders seeking the latest updates and insights on Celanese.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Celanese's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Celanese's position in the market.

News
Celanese to Hold First Quarter Earnings Conference Call on May 9, 2024
Rhea-AI Summary
Celanese (CE) will discuss its first quarter 2024 results in a conference call on May 9, 2024, accessible via webcast or phone. The earnings press release will be distributed after the New York Stock Exchange closes on May 8, 2024, with a replay available until May 23, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share
Rhea-AI Summary
Celanese (CE) announces a quarterly dividend of $0.70 per share, payable on May 13, 2024, to stockholders of record as of April 29, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
-
News
Chemical Marketing & Economics Honors Celanese Chairman, CEO and President Lori J. Ryerkerk with STEM Leadership Award for Corporate Reinvention
Rhea-AI Summary
Celanese Chairman, CEO, and President Lori J. Ryerkerk receives the CME STEM Leadership Award for Corporate Reinvention. The award recognizes her impact on Celanese's organizational direction and commitment to STEM talent programs. Celanese, a global chemistry leader, had $10.9 billion in net sales in 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.55%
Tags
none
News
Celanese Completes Series of Strategic Actions Across its Global Acetyl Chain
Rhea-AI Summary
Celanese (CE) announces strategic milestones to enhance competitive cost position and operational flexibility. Key highlights include a new 1.3 million ton Clear Lake acetic acid expansion, low-carbon methanol production, and VAE unit startup in Nanjing. These initiatives aim to meet future demand growth and increase earnings by $100 million to $1.4 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
none
-
News
Celanese Achieves ISCC CFC Certification for Low Carbon CCU Methanol
Rhea-AI Summary
Celanese , in partnership with Mitsui & Co., , has received ISCC certification for its Low Carbon CCU Methanol, showcasing over a 70% reduction in carbon footprint compared to traditional methods. The certification highlights Celanese's commitment to sustainability and offers customers eco-friendly options across its product range.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.75%
Tags
none
-
News
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
Rhea-AI Summary
Celanese and Secarna Pharmaceuticals announce a research collaboration to develop long-acting implants delivering antisense oligonucleotides for various diseases. The collaboration aims to reduce dosing frequency, minimize immune responses, and improve patient outcomes. Celanese's VitalDose® Drug Delivery Platform and Secarna's ASO Drug Discovery Platform will be utilized for this development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
none
News
Celanese Announces Commercial Launch of Glaukos'; iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA)
Rhea-AI Summary
Celanese Corporation collaborates with Glaukos Corporation to launch iDose® TR, a sustained drug release system for glaucoma treatment. The FDA-approved iDose® TR uses Celanese's VitalDose® EVA to deliver continuous dosing of travoprost, improving patient compliance and treatment outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.71%
Tags
none
-
News
Timothy Go Elected to Celanese Board of Directors
Rhea-AI Summary
Celanese Corporation (CE) announced the election of Timothy Go to its Board of Directors. Mr. Go, President and CEO of HF Sinclair Corporation, brings extensive leadership experience in the energy and specialty chemical industries. With a background in operational manufacturing excellence and strategic transformation, his appointment aims to enhance Celanese's Board composition and navigate the evolving manufacturing landscape.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.71%
Tags
management
-
News
Celanese Corporation Reports Full Year 2023 and Fourth Quarter Earnings
Rhea-AI Summary
Celanese Corporation (CE) reported strong financial results for full year 2023, with GAAP diluted earnings per share of $18.00 and adjusted earnings per share of $8.92. The company achieved net sales of $10.9 billion, a 13% increase from the prior year, driven by the Mobility & Materials acquisition. Despite a 10% decrease in price, the volume increased by 23%. Operating profit reached $1.7 billion, adjusted EBIT of $1.8 billion, and operating EBITDA of $2.4 billion. Celanese focused on reducing costs, improving cash flow, and deleveraging in 2023. The Acetyl Chain segment faced pricing challenges but managed to deliver solid earnings. Engineered Materials saw a 53% increase in net sales due to the M&M acquisition, although volume and pricing decreased. The company remains optimistic about future earnings growth supported by various projects and cost-saving initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
earnings
News
Celanese Low-Carbon ECO-CC Products Available Through U.S. Department of Energy Procurement Grant Program
Rhea-AI Summary
Celanese Corporation (CE) secures approval as a Utilization Procurement Grants vendor from the U.S. Department of Energy, offering low-carbon acetic acid under the ECO-CC product name. The company aims to support municipalities in meeting sustainability goals by providing circular solutions. Celanese's product offerings have shown significant reductions in greenhouse gas emissions and passed DOE's life cycle analysis review. This approval allows Celanese to work with value-chain partners to extend product usage opportunities to eligible U.S. government entities nationwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
none
Stock CE logo
Celanese Corp

NYSE:CE

CE Rankings

#561 Ranked by Market Cap
#981 Ranked by Stock Gains
#1497 Ranked by Dividends

CE Stock Data

17.41B
108.33M
0.4%
103.95%
4.5%
All Other Basic Organic Chemical Manufacturing
Manufacturing
Link
US
Irving

About CE

who is celanese? we’re engineers, scientists, operators and product developers. we’re innovators, advisers, designers and problem solvers. most importantly, we’re partners – in creating value for our customers with the solutions we offer and in improving the world through the actions of our colleagues. celanese is the chemistry inside innovation™ and we aspire to be the first-choice chemistry solution source for our customers. we know what you’re thinking – that’s a lot to promise and that’s a lot to do. well, we would agree with you, but we’re up for the challenge and we owe it to our customers, shareholders, and employees to deliver on our promise. what does celanese do? we produce products that make our lives a little easier, by helping customers to bring their inspired ideas and innovations to life. from the global production network of our acetyl chain, we provide materials that are critical to the global chemicals and paints and coatings industries. from our broad portfol